Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case report

Author： Pinter Matthias  

Publisher： Springer Publishing Company

ISSN： 0043-5325

Source： Wiener klinische Wochenschrift, Vol.123, Iss.1-2, 2011-01, pp. : 61-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression and Clinical Significance of the G1-S Modulators in Intrahepatic Cholangiocellular Carcinoma

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 242-251

Karger

Access to resources Recommend Favorite

Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 494-499

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 152-157

Karger

Access to resources Recommend Favorite

AFP Measurement in Monitoring Treatment Response of Advanced Hepatocellular Carcinoma to Sorafenib: Case Report and Review of the Literature

By  

Oncology Research and Treatment, Vol. 34, Iss. 10, 2011-09 ,pp. : 538-542

Karger

Access to resources Recommend Favorite

Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1581-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite